MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways

Sushmaa Chandralekha Selvakumar1, K Auxzilia Preethi1, Durairaj Sekar1

  • 1RNA Biology Lab, Centre for Cellular and Molecular Research, Saveetha Dental College & Hospitals, Saveetha Institute of Medical & Technical Sciences (SIMATS), Saveetha University, Chennai 600077, India.

Insights

This review explores microRNAs (miRNAs) that regulate the PTEN/PI3K/AKT pathway, a key player in cancer development. Understanding these miRNA-pathway interactions can reveal new therapeutic targets for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer remains a leading global cause of mortality.
  • Current cancer therapies face challenges due to lack of specificity and understanding of molecular mechanisms.
  • The PTEN/PI3K/AKT signaling pathway is crucial in cell proliferation, apoptosis, and tumor growth.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in regulating the PTEN/PI3K/AKT pathway.
  • To identify novel therapeutic strategies for cancer based on miRNA regulation of this pathway.

Main Methods:

  • Literature review focusing on studies investigating miRNAs and the PTEN/PI3K/AKT axis in carcinogenesis.
  • Analysis of the downstream effects of the PTEN/PI3K/AKT pathway, including malignancy, metastasis, and chemoresistance.

Main Results:

  • Identified various microRNAs (miRNAs) that significantly influence the PTEN/PI3K/AKT pathway.
  • Highlighted the involvement of these miRNAs in the pathogenesis of diverse cancers.
  • Demonstrated the potential of miRNAs in modulating tumor growth, metastasis, and chemoresistance via the PTEN/PI3K/AKT axis.

Conclusions:

  • MicroRNAs are critical regulators of the PTEN/PI3K/AKT pathway in cancer.
  • Targeting specific miRNAs offers a promising avenue for developing novel, targeted cancer therapeutics.
  • Further research into miRNA-PTEN/PI3K/AKT interactions can advance cancer treatment strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K